Stauft CB[au] - Search Results

Year	Number of Results
2013	1
2014	1
2015	2
2016	1
2018	2
2019	3
2020	2
2021	8
2022	2

1

Selective Targeting of Virus Replication by Proton Pump Inhibitors.

Watanabe SM, Ehrlich LS, Strickland M, Li X, Soloveva V, Goff AJ, Stauft CB, Bhaduri-McIntosh S, Tjandra N, Carter C. Watanabe SM, et al. Among authors: stauft cb. Sci Rep. 2020 Mar 4;10(1):4003. doi: 10.1038/s41598-020-60544-y. Sci Rep. 2020. PMID: 32132561 Free PMC article.

2

SARS-CoV-2 infection induces protective immunity and limits transmission in Syrian hamsters.

Selvaraj P, Lien CZ, Liu S, Stauft CB, Nunez IA, Hernandez M, Nimako E, Ortega MA, Starost MF, Dennis JU, Wang TT. Selvaraj P, et al. Among authors: stauft cb. Life Sci Alliance. 2021 Feb 11;4(4):e202000886. doi: 10.26508/lsa.202000886. Print 2021 Apr. Life Sci Alliance. 2021. PMID: 33574037 Free PMC article.

3

Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern.

Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft CB, Wang T, Golding B, Golding H, Khurana S. Tang J, et al. Among authors: stauft cb. iScience. 2021 Sep 24;24(9):103006. doi: 10.1016/j.isci.2021.103006. Epub 2021 Aug 20. iScience. 2021. PMID: 34430803 Free PMC article.

4

Structure-Function Analysis of Resistance to Bamlanivimab by SARS-CoV-2 Variants Kappa, Delta, and Lambda.

Liu S, Huynh T, Stauft CB, Wang TT, Luan B. Liu S, et al. Among authors: stauft cb. J Chem Inf Model. 2021 Oct 25;61(10):5133-5140. doi: 10.1021/acs.jcim.1c01058. Epub 2021 Oct 14. J Chem Inf Model. 2021. PMID: 34648284 Free PMC article.

5

Tailoring the Immune Response via Customization of Pathogen Gene Expression.

Runco LM, Stauft CB, Coleman JR. Runco LM, et al. Among authors: stauft cb. J Pathog. 2014;2014:651568. doi: 10.1155/2014/651568. Epub 2014 Feb 25. J Pathog. 2014. PMID: 24719769 Free PMC article. Review.

6

The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.

Stauft CB, Lien CZ, Selvaraj P, Liu S, Wang TT. Stauft CB, et al. Virology. 2021 Apr;556:96-100. doi: 10.1016/j.virol.2021.01.005. Epub 2021 Jan 25. Virology. 2021. PMID: 33556653 Free PMC article.

7

Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters.

Stauft CB, Tegenge M, Khurana S, Lee Y, Selvaraj P, Golding H, Wang T, Golding B. Stauft CB, et al. Clin Infect Dis. 2021 Sep 23:ciab854. doi: 10.1093/cid/ciab854. Online ahead of print. Clin Infect Dis. 2021. PMID: 34554235 Free PMC article.

8

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge.

Meseda CA, Stauft CB, Selvaraj P, Lien CZ, Pedro C, Nuñez IA, Woerner AM, Wang TT, Weir JP. Meseda CA, et al. Among authors: stauft cb. NPJ Vaccines. 2021 Dec 3;6(1):145. doi: 10.1038/s41541-021-00410-8. NPJ Vaccines. 2021. PMID: 34862398 Free PMC article.

9

SARS-CoV-2 B.1.1.7 infection of Syrian hamster does not cause more severe disease and is protected by naturally acquired immunity.

Nuñez IA, Lien CZ, Selvaraj P, Stauft CB, Liu S, Starost MF, Wang TT. Nuñez IA, et al. Among authors: stauft cb. bioRxiv. 2021 Apr 2:2021.04.02.438186. doi: 10.1101/2021.04.02.438186. Preprint. bioRxiv. 2021. PMID: 33821266 Free PMC article. Updated.

10

SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection.

Nuñez IA, Lien CZ, Selvaraj P, Stauft CB, Liu S, Starost MF, Wang TT. Nuñez IA, et al. Among authors: stauft cb. mSphere. 2021 Jun 16;6(3):e0050721. doi: 10.1128/mSphere.00507-21. Online ahead of print. mSphere. 2021. PMID: 34133199 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results